Xeris Biopharma Holdings, Inc.(XERS)

Research Snapshot

Xeris Biopharma Holdings, Inc. (XERS) is a Healthcare stock with a market cap of $1.09B and listed on NASDAQ. The stock last traded around $6.95 and up 49.8% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +43.7%, EPS growth of +100.9%, a dividend yield of 0.0%. What stands out right now is revenue +43.7%, EPS +100.9%, free cash flow +173.8% with operating margin 8.5% and ROIC 8.9%. Valuation already assumes a fairly strong business story at P/E 1899.3 and price/sales 3.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XERS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.